References
- Saber AA, Aboolian A, LaRaja RD, Baron H, Hanna K. HIV/AIDS and the risk of deep vein thrombosis: a study of 45 patients with lower extremity involvement. Am Surg 2001; 67(7): 645–7.
- Copur AS, Smith PR, Gomez V, Bergman M, Homel P. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS 2002; 16(5): 205–9.
- Witz M, Lehmann J, Korzets Z. Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection. Am J Hematol 2000; 64(2): 137–9.
- Wang L, Molina CP, Rajaraman S. Case report. Intestinal infarction due to vascular catastrophe in an HIV-infected patient. AIDS Read 2000; 10(12): 718–21.
- Bosson JL, Fleury-Feuillade ML, Farah I, Leclerc P. Arterial and venous thromboembolic disease in an HIV positive patient. J Mal Vasc 1995; 20(2): 136–8.
- Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001; 15(6): 311–20.
- Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343(7): 457–62.
- Kawasaki T, Kaida T, Arnout J, Vermylen J, Hoylaerts MF. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb Haemost 1999; 81(2): 306–11.
- O’Donnell J, Mumford AD, Manning RA, Laffan MA. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 2001; 115(3): 687–91.
- Bloemenkamp DG, van den Bosch MA, Mali WP, Tanis BC, Rosendaal FR, Kemmeren JM, et al. Novel risk factors for peripheral arterial disease in young women. Am J Med 2002; 113(6): 462–7.
- Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Brit Med J 2002; 325(7374): 1202.
- Bernasconi E, Uhr M, Magenta L, Ranno A, Telenti A. Swiss HIV Cohort Study. Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy. AIDS 2001; 15(8): 1081–2.
- Dierkes J, Westphal S, Luley C. Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management. Drug Saf 2003; 26(2): 81–91.
- Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M. Swiss HIV Cohort Study. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 2002; 185(4): 456–62.
- Saif MW, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS 2002; 15(1): 15–24.
- George SL, Swindells S, Knudson R, Stapleton JT. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of 7 cases. Am J Med 1999; 107(6): 624–30.